Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype
- PMID: 24659022
- PMCID: PMC4072897
- DOI: 10.1093/ntr/ntu010
Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype
Abstract
Introduction: Reactivity to smoking cues is an important factor in the motivation to smoke and has been associated with the dopamine receptor 4 variable number tandem repeat (DRD4 exon III VNTR) polymorphism. However, little is known about the associated neural mechanisms.
Methods: Non-treatment-seeking Caucasian smokers completed overnight abstinence and viewed smoking and neutral cues during 2 separate functional magnetic resonance imaging scans while wearing either a nicotine or placebo patch (order randomized) and were genotyped for the DRD4 VNTR. We conducted mixed-effects repeated-measures analyses of variance (within-subject factor: nicotine or placebo patch; between-subject factor: DRD4 long [L: ≥ 1 copy of ≥ 7 repeats] or short [S: 2 copies ≤ 6 repeats] genotype) of 6 a priori regions of interest.
Results: Relative to neutral cues, smoking cues elicited greater activity in bilateral ventral striatum and left amygdala during nicotine replacement and deactivation in these regions during nicotine deprivation. A patch × DRD4 interaction was observed in the left amygdala, an area associated with appetitive reinforcement and relapse risk, such that S allele carriers demonstrated greater activation on active patch than on placebo patch.
Conclusions: Brain systems associated with reward salience may become primed and overreactive at nicotine replacement doses intended for the first step of smoking cessation and may become inhibited during nicotine withdrawal in DRD4 S but not in DRD4 L carriers. These findings are consistent with the role of these regions in drug reinforcement and suggest a differential influence of nicotine replacement on amygdala activation in the association of incentive salience with smoking stimuli across DRD4 genotypes.
© The Author 2014. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward.Psychopharmacology (Berl). 2016 Jan;233(2):351-60. doi: 10.1007/s00213-015-4116-6. Psychopharmacology (Berl). 2016. PMID: 26497691 Free PMC article. Clinical Trial.
-
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.Pharmacogenomics J. 2008 Apr;8(2):122-8. doi: 10.1038/sj.tpj.6500447. Epub 2007 Mar 27. Pharmacogenomics J. 2008. PMID: 17387332 Free PMC article. Clinical Trial.
-
DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.Psychopharmacology (Berl). 2007 Nov;194(4):433-41. doi: 10.1007/s00213-007-0860-6. Epub 2007 Jul 5. Psychopharmacology (Berl). 2007. PMID: 17611740 Clinical Trial.
-
Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors.Nutrients. 2020 Jul 30;12(8):2288. doi: 10.3390/nu12082288. Nutrients. 2020. PMID: 32751662 Free PMC article. Review.
-
Parsing out the role of dopamine D4 receptor gene (DRD4) on alcohol-related phenotypes: A meta-analysis and systematic review.Addict Biol. 2020 May;25(3):e12770. doi: 10.1111/adb.12770. Epub 2019 May 31. Addict Biol. 2020. PMID: 31149768 Free PMC article.
Cited by
-
Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward.Psychopharmacology (Berl). 2016 Jan;233(2):351-60. doi: 10.1007/s00213-015-4116-6. Psychopharmacology (Berl). 2016. PMID: 26497691 Free PMC article. Clinical Trial.
-
Withdrawal: Expanding a Key Addiction Construct.Nicotine Tob Res. 2015 Dec;17(12):1405-15. doi: 10.1093/ntr/ntv048. Epub 2015 Mar 5. Nicotine Tob Res. 2015. PMID: 25744958 Free PMC article. Review.
-
Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.Mol Psychiatry. 2016 Aug;21(8):992-1008. doi: 10.1038/mp.2016.67. Epub 2016 May 10. Mol Psychiatry. 2016. PMID: 27166759 Free PMC article. Review.
-
Cue-reactivity in experienced electronic cigarette users: Novel stimulus videos and a pilot fMRI study.Brain Res Bull. 2016 May;123:23-32. doi: 10.1016/j.brainresbull.2015.10.003. Epub 2015 Oct 23. Brain Res Bull. 2016. PMID: 26478134 Free PMC article.
-
Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction.J Neural Transm (Vienna). 2019 Feb;126(2):193-199. doi: 10.1007/s00702-018-1946-5. Epub 2018 Oct 26. J Neural Transm (Vienna). 2019. PMID: 30367264
References
-
- Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H. H. (1995). Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry, 65, 1157–1165. 10.1046/j.1471-4159.1995.65031157.x - PubMed
-
- Asghari V., Schoots O., van Kats S., Ohara K., Jovanovic V., Guan H. C., … Van Tol H. H. (1994). Dopamine D4 receptor repeat: Analysis of different native and mutant forms of the human and rat genes. Molecular Pharmacology, 46, 364–373 Retrieved from http://molpharm.aspetjournals.org/content/46/2/364.abstract - PubMed
-
- Balleine B. W., Killcross S. (2006). Parallel incentive processing: An integrated view of amygdala function. Trends in Neurosciences, 29, 272–279. 10.1016/j.tins.2006.03.002 - PubMed
-
- Blum K., Cull J. G., Braverman E. R., Comings D. E. (1996). Reward deficiency syndrome. American Scientist, 84, 132–145 Retrieved from http://www.americanscientist.org/
Publication types
MeSH terms
Substances
Grants and funding
- T32 AA007459/AA/NIAAA NIH HHS/United States
- DA023134/DA/NIDA NIH HHS/United States
- NIDA T32DA016184/PHS HHS/United States
- R25 MH080663/MH/NIMH NIH HHS/United States
- NCI CA8471909-S1/CA/NCI NIH HHS/United States
- 2T32HL076134-06/HL/NHLBI NIH HHS/United States
- P50CA084719-060002/CA/NCI NIH HHS/United States
- K23 MH096628/MH/NIMH NIH HHS/United States
- 1S10RR023457-01A1/RR/NCRR NIH HHS/United States
- DA017441/DA/NIDA NIH HHS/United States
- K23AA016936-02/AA/NIAAA NIH HHS/United States
- K23 AA016936/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources